Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Spain- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Spain24 clinical trials in Boadilla Del Monte, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on vaccine development and immune responses for multiple infectious diseases, including studies of combination vaccines for childhood diseases and COVID-19 boosters.
Special emphasis on pediatric populations and vaccine co-administration safety protocols.
Comprehensive studies on various cancer types, with focus on pediatric liver cancers and innovative treatment approaches for solid tumors.
Integration of targeted therapies and combination treatment protocols.
Investigations into cardiovascular disease prevention and treatment, particularly focusing on post-heart attack care and preventive measures.
Emphasis on long-term cardiovascular outcomes and preventive strategies.
Studies examining reproductive health and related conditions, including contraceptive efficacy and treatments for gynecological infections.
Focus on innovative delivery systems and treatment options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.